Evidence map›Paper›PMID 32126968›Full record

ArticleBMC microbiology2020

The influence of blood on the human gut microbiome.

Thierry Chénard, Mandy Malick, Jean Dubé, Eric Massé

Open access · goldAbstract read
In one paragraph

Article in BMC microbiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 48 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. The effect of short-term consumption ofExperimental biology and medicine (Maywood, N.J.) · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Influence of CTG repeats from the human DM1 locus on murine gut microbiota.Computational and structural biotechnology journal · 2025
    Article
  10. Article
  11. Article
  12. Disturbance of the human gut microbiota in patients with Myotonic Dystrophy type 1.Computational and structural biotechnology journal · 2024
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Thierry ChénardDepartment of Biochemistry, Université de Sherbrooke, 3201 Jean-Mignault Street, Sherbrooke, Sherbrooke, QC, J1E 4K8, Canada.
Mandy MalickDepartment of Biochemistry, Université de Sherbrooke, 3201 Jean-Mignault Street, Sherbrooke, Sherbrooke, QC, J1E 4K8, Canada.
Jean DubéDepartment of Biochemistry, Université de Sherbrooke, 3201 Jean-Mignault Street, Sherbrooke, Sherbrooke, QC, J1E 4K8, Canada.
Eric MasséDepartment of Biochemistry, Université de Sherbrooke, 3201 Jean-Mignault Street, Sherbrooke, Sherbrooke, QC, J1E 4K8, Canada. eric.masse@usherbrooke.ca.ORCID 0000-0002-5253-1415
Université de Sherbrooke · CA

Funding

CIHR MOP69005
6 · The paper itself

Abstract

backgroundColorectal cancer (CRC) is one of the prevailing causes of cancer mortality in the world. A common screening test for CRC is based on the human hemoglobin immunochemical based fecal occult blood test (iFOBT), which consists in the detection of blood in the patient's stool. In addition to iFOBT, recent studies support the use of the gut microbiome as a biomarker for CRC prediction. However, these studies did not take into account the effect of blood itself on the microbiome composition, independently of CRC. Therefore, we investigated the microbiome of patients undergoing the iFOBT screening in order to determine the effect of blood alone. Our cohort consisted of patients who had no blood in their stools (n = 265) or did have blood but no underlying precancerous or cancerous lesions (n = 235). We also identified bacterial taxa specifically associated with the presence of blood in stools.

resultsWe observed significant differences in the intestinal bacterial composition that could be solely caused by the presence of blood in stools. More precisely, we identified 12 bacterial species showing significant differences in abundance between both our study groups. These species, Bacteroides uniformis, Collinsella aerofaciens, Eggerthella lenta and Clostridium symbiosum demonstrated increased abundance in the presence of blood. In contrast, the species Prevotella copri, Coprococcus eutactus and catus, Faecalibacterium prausnitzii, Roseburia faecis, Blautia obeum, Gemmiger formicilis and Clostridium celatum showed decreased abundance in patients with blood in their stools. Notably, we found multiple taxa that were reported in previous studies linking microbiome composition and diseases.

conclusionsWe show that, in the absence of disease, blood in the stools has a major influence on the composition of the microbiome. Our data suggest that blood itself should be taken into consideration when investigating the microbiome signatures of intestinal diseases.

Indexed as

AgedBacteriaDNA, BacterialDNA, RibosomalFemaleGastrointestinal TractHumansMaleMiddle AgedOccult BloodPhylogenyRNA, Ribosomal, 16SSequence Analysis, DNADNA, BacterialDNA, RibosomalRNA, Ribosomal, 16S16S rRNA gene amplicon sequencingBacteriaBloodColorectal cancerGut microbiotaiFOBT testingLefSeTaxonomic biomarkers

Identifiers

PMID32126968
PMCPMC7055051
OpenAlexW3010646857

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.